Cargando…

COVID-19-Associated Cardiovascular Complications

Coronavirus disease 2019 (COVID-19) has been reported to cause cardiovascular complications such as myocardial injury, thromboembolic events, arrhythmia, and heart failure. Multiple mechanisms—some overlapping, notably the role of inflammation and IL-6—potentially underlie these complications. The r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Clement C. E., Ali, Kashan, Connell, David, Mordi, Ify R., George, Jacob, Lang, Elizabeth MSL, Lang, Chim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293160/ https://www.ncbi.nlm.nih.gov/pubmed/34209705 http://dx.doi.org/10.3390/diseases9030047

Ejemplares similares

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure
por: Steggall, Abbey, et al.
Publicado: (2017)

Plasma desmosine for prediction of outcomes after acute myocardial infarction
por: Ali, Kashan, et al.
Publicado: (2022)

Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases
por: Mordi, Ify R., et al.
Publicado: (2020)

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial
por: Mordi, Natalie A., et al.
Publicado: (2020)

Nicorandil‐induced colovesical fistula in a patient with diverticular disease
por: Noyes, James D., et al.
Publicado: (2021)

Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK
por: Mordi, Ify R., et al.
Publicado: (2020)

Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
por: Mordi, Natalie A, et al.
Publicado: (2017)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
por: Mordi, Ify R., et al.
Publicado: (2020)

Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease
por: Mordi, Ify R, et al.
Publicado: (2017)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study
por: Mordi, Ify R., et al.
Publicado: (2021)

Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
por: Singh, Jagdeep S. S., et al.
Publicado: (2016)

The combined incremental prognostic value of left ventricular ejection fraction, late gadolinium enhancement and global circumferential strain assessed by cardiovascular magnetic resonance
por: Mordi, Ify, et al.
Publicado: (2015)

Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes
por: Al-Talabany, Shaween, et al.
Publicado: (2018)

Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction
por: Akbar, Naveed, et al.
Publicado: (2021)

Non-Invasive Imaging in Diabetic Cardiomyopathy
por: Mordi, Ify R.
Publicado: (2019)

Bicuspid Aortic Valve Disease: A Comprehensive Review
por: Mordi, Ify, et al.
Publicado: (2012)

Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
por: Singh, Jagdeep S.S., et al.
Publicado: (2020)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Zhou, Yiling, et al.
Publicado: (2021)

Utility of Native T1 mapping to differentiate between athlete's heart and non-ischemic dilated cardiomyopathy
por: Mordi, Ify, et al.
Publicado: (2015)

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
por: Mohan, Mohapradeep, et al.
Publicado: (2019)

Plasma Desmosine and Abdominal Aortic Aneurysm Disease
por: Mordi, Ify R., et al.
Publicado: (2019)

Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes
por: George, Jacob, et al.
Publicado: (2019)

Contrast Induced Nephropathy: Efficacy of matched hydration and forced diuresis for prevention in patients with impaired renal function undergoing coronary procedures–CINEMA trial
por: Mirza, Aram J., et al.
Publicado: (2022)

Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction
por: Curran, Fraser M., et al.
Publicado: (2021)

Cardiovascular complications in COVID-19
por: Long, Brit, et al.
Publicado: (2020)

Cardiovascular complications in COVID-19
por: Butt, Nausharwan, et al.
Publicado: (2021)

Cardiovascular complications of COVID-19
por: Farshidfar, Farnaz, et al.
Publicado: (2021)

CARDIOVASCULAR COMPLICATIONS OF COVID-19
por: Terzic, Carmen M., et al.
Publicado: (2023)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Touyz, Rhian M., et al.
Publicado: (2021)

Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections
por: Briller, Joan E., et al.
Publicado: (2022)

What Risk Factors Are Associated with Cardiovascular Complications in Patients with COVID-19?
por: Roser, Lynn P., et al.
Publicado: (2021)

Pathophysiology of Cardiovascular Complications in COVID-19
por: Petrovic, Vladimir, et al.
Publicado: (2020)

Cardiovascular Complications of COVID-19 Vaccines
por: Liu, Runyu, et al.
Publicado: (2022)

Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
por: Singh, Jagdeep SS, et al.
Publicado: (2015)

Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies
por: Samidurai, Arun, et al.
Publicado: (2020)

Sex-Related Factors in Cardiovascular Complications Associated to COVID-19
por: Megiorni, Francesca, et al.
Publicado: (2021)

Resting Heart Rate and Outcomes in Patients with Cardiovascular Disease: Where Do We Currently Stand?
por: Menown, Ian BA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mdt0efe4hamsoat07rmopt221u